Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Molecular profiling of neoadjuvant tamoxifen or exemestane in postmenopausal women with breast cancer
ISRCTN87408408Phase 2Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Jan 2007
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial in breast cancer comparing Tamoxifen with Exemestane (2 arms). Primary endpoint: Predictive molecular markers of response or resistance. Started Jan 2007; status: completed.
02
Drugs
tamoxifenexemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on ISRCTN87408408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN87408408.